RNF144B negatively regulates antiviral immunity by targeting MDA5 for autophagic degradation.

IF 6.5 1区生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

EMBO Reports Pub Date : 2024-09-16 DOI:10.1038/s44319-024-00256-w

Guoxiu Li,Jing Zhang,Zhixun Zhao,Jian Wang,Jiaoyang Li,Weihong Xu,Zhanding Cui,Pu Sun,Hong Yuan,Tao Wang,Kun Li,Xingwen Bai,Xueqing Ma,Pinghua Li,Yuanfang Fu,Yimei Cao,Huifang Bao,Dong Li,Zaixin Liu,Ning Zhu,Lijie Tang,Zengjun Lu

引用次数: 0

Abstract

As a RIG-I-like receptor, MDA5 plays a critical role in antiviral innate immunity by acting as a cytoplasmic double-stranded RNA sensor capable of initiating type I interferon pathways. Here, we show that RNF144B specifically interacts with MDA5 and promotes K27/K33-linked polyubiquitination of MDA5 at lysine 23 and lysine 43, which promotes autophagic degradation of MDA5 by p62. Rnf144b deficiency greatly promotes IFN production and inhibits EMCV replication in vivo. Importantly, Rnf144b-/- mice has a significantly higher overall survival rate than wild-type mice upon EMCV infection. Collectively, our results identify RNF144B as a negative regulator of innate antiviral response by targeting CARDs of MDA5 and mediating autophagic degradation of MDA5.

查看原文本刊更多论文

RNF144B 通过靶向 MDA5 进行自噬降解来负向调节抗病毒免疫。

作为一种类似 RIG-I 的受体，MDA5 在抗病毒先天免疫中发挥着关键作用，它是一种细胞质双链 RNA 传感器，能够启动 I 型干扰素通路。在这里，我们发现 RNF144B 与 MDA5 有特异性相互作用，并促进 MDA5 在赖氨酸 23 和赖氨酸 43 上的 K27/K33 链接多泛素化，从而促进 p62 对 MDA5 的自噬降解。缺乏 Rnf144b 会大大促进 IFN 的产生并抑制 EMCV 在体内的复制。重要的是，Rnf144b-/-小鼠感染EMCV后的总存活率明显高于野生型小鼠。总之，我们的研究结果表明，RNF144B 通过靶向 MDA5 的 CARDs 和介导 MDA5 的自噬降解，是先天性抗病毒反应的负调控因子。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

EMBO Reports 生物-生化与分子生物学

CiteScore

11.20

自引率

1.30%

发文量

267

审稿时长

1 months

期刊介绍： EMBO Reports is a scientific journal that specializes in publishing research articles in the fields of molecular biology, cell biology, and developmental biology. The journal is known for its commitment to publishing high-quality, impactful research that provides novel physiological and functional insights. These insights are expected to be supported by robust evidence, with independent lines of inquiry validating the findings. The journal's scope includes both long and short-format papers, catering to different types of research contributions. It values studies that: Communicate major findings: Articles that report significant discoveries or advancements in the understanding of biological processes at the molecular, cellular, and developmental levels. Confirm important findings: Research that validates or supports existing knowledge in the field, reinforcing the reliability of previous studies. Refute prominent claims: Studies that challenge or disprove widely accepted ideas or hypotheses in the biosciences, contributing to the correction and evolution of scientific understanding. Present null data: Papers that report negative results or findings that do not support a particular hypothesis, which are crucial for the scientific process as they help to refine or redirect research efforts. EMBO Reports is dedicated to maintaining high standards of scientific rigor and integrity, ensuring that the research it publishes contributes meaningfully to the advancement of knowledge in the life sciences. By covering a broad spectrum of topics and encouraging the publication of both positive and negative results, the journal plays a vital role in promoting a comprehensive and balanced view of scientific inquiry.